Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Baker Mark Robert
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
185%
Avg. Purchase Return
69%
Compound
(56%)
Avg. Sale Return
(25%)
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
23%
41%
97%
84%
185%
Purchase Success Rate
6 of 14
5 of 14
7 of 14
8 of 14
5 of 14
Average Sale Return
17%
10%
22%
(21%)
(56%)
Sale Success Rate
2 of 3
2 of 3
3 of 3
0 of 3
0 of 3
Progenics Pharmaceuticals I...
Drugs
» Biotechnology
Chief Executive Officer, Director:
Holdings:
161.14K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--